KORU Medical Systems Inc. logo

KORU Medical Systems Inc.

KRMD | NASDAQ
Chart Builder DCF Calculator
$3.31
+$0.08 (+2.48%)
At close: Sep 22, 2026, 4:00 PM ET
$3.31
$0 (0.00%)
After-hours: Sep 22, 2026, 4:53 PM ET

Market Data

Market Cap
$148.36M
Enterprise Value
$143.31M
Beta
0.42
Average Volume
173.79K
Shares Outstanding (Diluted)
49.51M
Shares Change YoY
7.18%
Institutional Ownership
44.96%
Exchange
NASDAQ
ISIN
US7599101026

Price Performance

Price Change 1M
0.6%
Price Change 3M
-21.8%
Price Change 6M
-26.8%
Price Change YTD
-42.4%
Price Change 1Y
-19.6%
Price Change 3Y
15.4%
Price Change 5Y
5.9%
1M CAGR (ann.)
-9.0%
1Y CAGR (ann.)
-20.1%
5Y CAGR (ann.)
1.7%
All-Time CAGR
20.8%

Valuation

PE Ratio
-93.08
Forward PE
155.49
PEG Ratio
-0.74
Forward PEG
0.54
PS Ratio
3.29
Forward PS
2.60
PB Ratio
8.22
P/FCF Ratio
211.52
P/Adj. FCF Ratio
-70.91
P/OCF Ratio
107.67
EV/Sales
3.18
EV/EBIT
-79.22
EV/EBITDA
-140.79
EV/FCF
204.32
Earnings Yield
-1.1%
FCF Yield
0.5%
Adj. FCF Yield
-1.4%

Financial Health

Net Cash
$8.29M
Total Debt
$3.24M
Cash & Short-Term Investments
$8.29M
Total Assets
$27.96M
Current Ratio
2.72
Quick Ratio
2.09
Debt / Equity Ratio
0.18
Debt / EBITDA
-3.18
Debt / FCF
4.62
OCF / Debt
0.43
Interest Coverage
0.00
Altman Z-Score
9.28
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
62.0%
Operating Profit Margin
-3.7%
EBITDA Margin
-2.3%
Net Profit Margin
-4.0%
FCF Margin
1.6%
Adj. FCF Margin
-4.6%
SBC / Revenue
4.7%
SBC Impact (per share)
-398.3%

Returns

Return on Assets
-6.5%
Return on Equity
-10.6%
Return on Invested Capital
-7.7%
Return on Capital Employed
-8.0%
Return on Tangible Assets
-6.9%

Historical Growth (CAGR)

Revenue CAGR 3Y
15.3%
Revenue CAGR 5Y
16.4%
Revenue CAGR 10Y
13.6%
EPS CAGR 3Y
84.0%
EPS CAGR 5Y
23.9%
EPS CAGR 10Y
-25.8%
FCF CAGR 3Y
103.8%
FCF CAGR 5Y
64.0%
FCF CAGR 10Y
-7.1%

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
5
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
Nov 10, 2026
EPS Estimate (next Q)
-$0.02
EPS Growth Est (next Q)
-16.0%
Revenue Est (next Q)
$11.33M
Revenue Growth Est (next Q)
8.9%

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$6
Price Target Upside
85.8%

Cash Flow

Operating Cash Flow
$1.41M
Free Cash Flow
$701.43K
Adj. Free Cash Flow
$-2.09M
FCF Per Share
$0.01
OCF Per Share
$0.03
OCF/S Ratio
3.1%

Income Statement

Revenue
$45.11M
Gross Profit
$27.96M
Operating Income
$-1.65M
EBITDA
$-1.02M
Net Income
$-1.82M
EPS (Diluted)
-$0.03
Revenue / Employee
$617.91K
Profit / Employee
$-24.92K
Employees
73

© 2026 bestshares.com. All rights reserved.